We will be taking part in the ICFSR conference

We will be taking part in the upcoming hybrid ICFSR conference taking place in Boston, US from 20-22nd April.

Our CEO, Thomas Holm Pedersen will present on the panel “Neuromuscular Junction Transmission Failure In Sarcopenia” on the 21st April alongside are professor Brian C. Clark (Ohio University) and professor W. David Arnold (The Ohio State University). They are close collaborators with NMDPharma on Sarcopenia observational studies.

 We look forward to seeing you there!

Our CEO, Thomas Holm Pedersen is here together with professor William David Arnold and our Clinical Trial Manager, Thomas Skjærlund Grønnebæk